Gus Zamora, MD
Obstetrics & Gynecology · Victoria, TXNPI 1053601518
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $805 of the $905 with a category attached, or 88.9%. It is spread thinly across 19 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $250 and has fallen 91.0% since, to $22 in 2025. That places this record below the midpoint for obstetrics & gynecology clinicians in TX, where the typical reported total is $863.
Across 47 payments — averaging $19.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Avion Pharmaceuticals$150
- Astellas Pharma US Inc$149
- AbbVie$122
- Mayne Pharma Commercial LLC$65
- Exeltis, USA Inc.$52
- Hologic Sales And Service, LLC$47
- plus $319 from 13 others
What the payments were for
- Food & beverage$80589%
- Education$10011%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Avion Pharmaceuticals | 10 | $150 |
| Astellas Pharma US Inc | 4 | $149 |
| AbbVie(2 entities) | 7 | $122 |
| Mayne Pharma Commercial LLC | 2 | $65 |
| Exeltis, USA Inc. | 3 | $52 |
| Hologic Sales And Service, LLC | 3 | $47 |
| Smith+Nephew | 2 | $43 |
| Myovant Sciences Inc. | 2 | $41 |
| Boston Scientific | 2 | $39 |
| Bayer | 2 | $32 |
| Merck | 2 | $29 |
| Acessa Health Inc. | 1 | $24 |
| Evofem Biosciences, Inc. | 1 | $22 |
| Roche Diagnostics Corporation | 1 | $16 |
| Shield Therapeutics Inc | 1 | $16 |
| Therapeuticsmd, Inc. | 1 | $15 |
| Agile Therapeutics, Inc. | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
| Urovant Sciences Inc | 1 | $13 |
How this compares
$905 in reported general payments places this provider in the 50th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 39 | $1,746 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $443 |
| Norethindrone | 12 | $257 |
| Ciprofloxacin Hcl | 11 | $59 |
| Amitriptyline Hcl | 12 | $43 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Victoria
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
- Rene LunaMcAllen$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.